BridgeBio Pharma (BBIO) News Today $47.69 +1.22 (+2.63%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$48.36 +0.66 (+1.39%) As of 07/14/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BBIO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Piper Sandler Issues Positive Forecast for BridgeBio Pharma (NASDAQ:BBIO) Stock Price1 hour ago | americanbankingnews.comPiper Sandler Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) StockJuly 14 at 9:35 AM | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Now Covered by Jefferies Financial GroupJuly 14 at 8:44 AM | marketbeat.comCitigroup Issues Positive Forecast for BridgeBio Pharma (NASDAQ:BBIO) Stock PriceJuly 14 at 2:17 AM | americanbankingnews.comAllspring Global Investments Holdings LLC Makes New $251,000 Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)July 12 at 3:18 AM | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Rating Increased to Outperform at OppenheimerJuly 12 at 2:17 AM | americanbankingnews.comBridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, Citigroup Analyst SaysJuly 11, 2025 | marketbeat.comCaas Capital Management LP Takes $297,000 Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)July 11, 2025 | marketbeat.comOppenheimer Upgrades BridgeBio Pharma (BBIO)July 10, 2025 | msn.comBridgeBio Pharma (NASDAQ:BBIO) Hits New 52-Week High - Time to Buy?July 9, 2025 | marketbeat.comOppenheimer Upgrades BridgeBio Pharma (NASDAQ:BBIO) to OutperformJuly 9, 2025 | marketbeat.comBridgeBio Pharma (BBIO) Opinions on $300 Million Royalty Financing Deal - NasdaqJuly 8, 2025 | nasdaq.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Stock Holdings Increased by Principal Financial Group Inc.July 7, 2025 | marketbeat.comBridgeBio Pharma Raises $300M Through Partial European Royalty Monetization for BEYONTTRAJuly 6, 2025 | msn.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) CEO Sells $1,701,600.00 in StockJuly 6, 2025 | americanbankingnews.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Cambridge Investment Research Advisors Inc.July 6, 2025 | marketbeat.comLeerink Partnrs Issues Negative Estimate for BBIO EarningsJuly 5, 2025 | americanbankingnews.comNeil Kumar Sells 40,000 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) StockJuly 3, 2025 | marketbeat.comLeerink Partnrs Expects Lower Earnings for BridgeBio PharmaJuly 3, 2025 | marketbeat.comBridgeBio (BBIO) Tanks After Selling Beyonttra Royalty RightsJuly 3, 2025 | msn.comInsider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) Major Shareholder Sells 3,500,000 Shares of StockJuly 2, 2025 | insidertrades.comGlobal Investors Lp Viking Sells 3,500,000 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) StockJuly 1, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Sells $106,512.90 in StockJune 30, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $76.00June 30, 2025 | marketbeat.comBridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European RoyaltyJune 30, 2025 | globenewswire.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Average Recommendation of "Moderate Buy" from AnalystsJune 30, 2025 | marketbeat.comBBIO BridgeBio Pharma, Inc. - Seeking AlphaJune 29, 2025 | seekingalpha.comDiversified Trust Co Raises Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)June 29, 2025 | marketbeat.comBBIO Stock Price Quote | MorningstarJune 28, 2025 | morningstar.comMBridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Frank Mccormick Sells 100,000 SharesJune 27, 2025 | insidertrades.comFrank Mccormick Sells 100,000 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) StockJune 26, 2025 | marketbeat.comBridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ETJune 26, 2025 | globenewswire.comBank of America Issues Positive Forecast for BridgeBio Pharma (NASDAQ:BBIO) Stock PriceJune 25, 2025 | marketbeat.comBBIO - BridgeBio Pharma Inc Key Metrics - MorningstarJune 24, 2025 | morningstar.comMBridgeBio Pharma (NASDAQ:BBIO) Sets New 12-Month High - Here's What HappenedJune 23, 2025 | marketbeat.comWolfe Research Initiates Coverage of BridgeBio Pharma (BBIO) with ‘Outperform’ RatingJune 20, 2025 | msn.comBridgeBio Pharma (NASDAQ:BBIO) Now Covered by Wolfe ResearchJune 17, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Hits New 52-Week High - Here's What HappenedJune 17, 2025 | marketbeat.comGAMMA Investing LLC Boosts Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)June 16, 2025 | marketbeat.comAssenagon Asset Management S.A. Buys 1,096,799 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)June 13, 2025 | marketbeat.comBridgeBio Pharma, Inc. (BBIO) Price Target Raised to $56 from $53 at H.C. WainwrightJune 11, 2025 | insidermonkey.comBridgeBio Pharma, Inc. (BBIO) Price Target Raised to $56 from $53 at H.C. WainwrightJune 11, 2025 | msn.comHannah Valantine Sells 4,292 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) StockJune 11, 2025 | marketbeat.comCantor Fitzgerald Estimates BBIO FY2026 EarningsJune 11, 2025 | marketbeat.comHC Wainwright Boosts Earnings Estimates for BridgeBio PharmaJune 11, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for BridgeBio Pharma (NASDAQ:BBIO) Stock PriceJune 9, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Moss Adams Wealth Advisors LLCJune 9, 2025 | marketbeat.comWall Street Zen Upgrades BridgeBio Pharma (NASDAQ:BBIO) to HoldJune 7, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's What HappenedJune 6, 2025 | marketbeat.comCalifornia State Teachers Retirement System Raises Stock Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)June 5, 2025 | marketbeat.com Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address BBIO Media Mentions By Week BBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBIO News Sentiment▼0.930.99▲Average Medical News Sentiment BBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBIO Articles This Week▼169▲BBIO Articles Average Week Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BioNTech News BeOne Medicines News Teva Pharmaceutical Industries News Insmed News Summit Therapeutics News Intra-Cellular Therapies News Genmab A/S News Dr. Reddy's Laboratories News Moderna News Regencell Bioscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBIO) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBIO Stock Alerts